• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类病态肥胖中胰多肽、胰高血糖素、肠高血糖素和胰岛素的昼夜变化情况。

Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity.

作者信息

Holst J J, Schwartz T W, Lovgreen N A, Pedersen O, Beck-Nielsen H

出版信息

Int J Obes. 1983;7(6):529-38.

PMID:6360922
Abstract

The diurnal profiles of pancreatic glucagon, insulin, pancreatic polypeptide (PP), and enteroglucagon were studied in five obese non-diabetic subjects (195 +/- 11 per cent of ideal body weight) and in six age matched controls. All the subjects were served with ordinary mixed meals five times during the day. The obese subjects were normoglycemic but hyperinsulinemic. Both groups showed rapid increases in PP to all meals, but the PP-response was significantly impaired in the obese group during the first part of the day. Normal subjects showed significant enteroglucagon responses to all meals, and had elevated levels throughout the day. In obese subjects, levels and responses were much lower at all times. Pancreatic glucagon profiles were similar. It is concluded that the possible role of abnormalities of PP and enteroglucagon secretion in the pathogenesis of human obesity deserves further study.

摘要

在五名肥胖非糖尿病受试者(体重为理想体重的195±11%)和六名年龄匹配的对照者中,研究了胰高血糖素、胰岛素、胰多肽(PP)和肠高血糖素的昼夜变化情况。所有受试者在一天中进食五次普通混合餐。肥胖受试者血糖正常但胰岛素水平升高。两组对所有餐食的PP均迅速升高,但肥胖组在一天的第一时段PP反应明显受损。正常受试者对所有餐食均有明显的肠高血糖素反应,且全天水平升高。肥胖受试者在所有时间的水平和反应均低得多。胰高血糖素的变化情况相似。结论是,PP和肠高血糖素分泌异常在人类肥胖发病机制中的可能作用值得进一步研究。

相似文献

1
Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity.人类病态肥胖中胰多肽、胰高血糖素、肠高血糖素和胰岛素的昼夜变化情况。
Int J Obes. 1983;7(6):529-38.
2
Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation.病态肥胖及胃旁路手术后的胰多肽、胰高血糖素和肠高血糖素
Int J Obes. 1986;10(1):37-42.
3
Gut and pancreatic hormones after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.
Digestion. 1983;26(3):137-45. doi: 10.1159/000198880.
4
Diurnal GIP, PP and insulin levels in morbid obesity before and after stapled gastric partitioning with gastro-gastrostomy.胃旁路胃吻合术后病态肥胖患者日间胃抑制多肽、胰多肽和胰岛素水平的变化
Int J Obes. 1984;8(2):117-22.
5
Simultaneous recording of the gastro-entero-pancreatic hormonal peptide response to food in man.人体胃肠道胰腺激素对食物反应的同步记录。
Metabolism. 1980 Aug;29(8):777-9. doi: 10.1016/0026-0495(80)90203-6.
6
[Pancreatic polypeptide response to oral glucose load in patients with liver cirrhosis--interrelationship between PP and other pancreatic endocrine hormones].[肝硬化患者口服葡萄糖负荷后胰多肽的反应——胰多肽与其他胰腺内分泌激素之间的相互关系]
Nihon Naibunpi Gakkai Zasshi. 1988 Mar 20;64(3):155-70. doi: 10.1507/endocrine1927.64.3_155.
7
Pancreatic and gastrointestinal hormones in chronic pancreatitis.慢性胰腺炎中的胰腺和胃肠激素
Digestion. 1982;24(3):195-208. doi: 10.1159/000198797.
8
Gut hormones in acute diarrhoea.急性腹泻中的肠道激素
Gut. 1983 Jul;24(7):665-71. doi: 10.1136/gut.24.7.665.
9
The effect of pirenzepine on meal-stimulated gastrointestinal hormones.哌仑西平对进餐刺激的胃肠激素的影响。
Scand J Gastroenterol Suppl. 1980;66:57-61.
10
[Pancreatic glucagon and enteroglucagon in the plasma of patients with liver cirrhosis].[肝硬化患者血浆中的胰高血糖素和肠高血糖素]
Pol Arch Med Wewn. 1983 Apr-May;69(4-5):315-23.

引用本文的文献

1
The Enteric Neuronal Circuitry: A Key Ignored Player in Nutrient Sensing Along the Gut-Brain Axis.肠神经元回路:肠-脑轴营养感知中被忽视的关键参与者。
FASEB J. 2025 May 15;39(9):e70586. doi: 10.1096/fj.202500220RR.
2
GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management.肥胖中的胰高血糖素样肽-1生理机制及用于慢性体重管理的肠促胰岛素类药物的研发。
Nat Metab. 2024 Oct;6(10):1866-1885. doi: 10.1038/s42255-024-01113-9. Epub 2024 Aug 19.
3
Glucagon and other proglucagon-derived peptides in the pathogenesis of obesity.
胰高血糖素及其他胰高血糖素原衍生肽在肥胖发病机制中的作用
Front Nutr. 2022 Aug 4;9:964406. doi: 10.3389/fnut.2022.964406. eCollection 2022.
4
Brain GLP-1 and the regulation of food intake: GLP-1 action in the brain and its implications for GLP-1 receptor agonists in obesity treatment.脑内 GLP-1 与食物摄入的调节:GLP-1 在大脑中的作用及其对肥胖治疗中 GLP-1 受体激动剂的意义。
Br J Pharmacol. 2022 Feb;179(4):557-570. doi: 10.1111/bph.15638. Epub 2021 Aug 28.
5
Appetite Control across the Lifecourse: The Acute Impact of Breakfast Drink Quantity and Protein Content. The Full4Health Project.生命全程中的食欲控制:早餐饮料量和蛋白质含量的急性影响。全 4 健康项目。
Nutrients. 2020 Nov 30;12(12):3710. doi: 10.3390/nu12123710.
6
Whey Proteins Reduce Appetite, Stimulate Anorexigenic Gastrointestinal Peptides and Improve Glucometabolic Homeostasis in Young Obese Women.乳清蛋白可降低食欲,刺激食欲抑制性胃肠道肽,并改善年轻肥胖女性的糖代谢稳态。
Nutrients. 2019 Jan 23;11(2):247. doi: 10.3390/nu11020247.
7
Combining Short-Term Interval Training with Caloric Restriction Improves ß-Cell Function in Obese Adults.短期间歇训练与热量限制相结合可改善肥胖成年人的胰岛β细胞功能。
Nutrients. 2018 Jun 3;10(6):717. doi: 10.3390/nu10060717.
8
Alterations in circadian and meal-induced gut peptide levels in lean and obese rats.瘦鼠和肥胖大鼠昼夜节律及进食诱导的肠道肽水平变化
Exp Biol Med (Maywood). 2017 Dec;242(18):1786-1794. doi: 10.1177/1535370217732041. Epub 2017 Sep 15.
9
Pediatric Metabolic Syndrome: Pathophysiology and Laboratory Assessment.小儿代谢综合征:病理生理学与实验室评估
EJIFCC. 2017 Mar 8;28(1):25-42. eCollection 2017 Mar.
10
Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes.将胰高血糖素样肽-1信号通路作为糖尿病心血管疾病的一种新型治疗方法进行选择性靶向。
Br J Pharmacol. 2015 Feb;172(3):721-36. doi: 10.1111/bph.12943. Epub 2014 Dec 1.